rLP2086
Showing 1 - 21 of 21
Meningococcal B Disease Trial in Worldwide (rLP2086 vaccine, Pediatric HAV vaccine)
Completed
- Meningococcal B Disease
- rLP2086 vaccine
- Pediatric HAV vaccine
-
Canberra, Garran, Australian Capital Territory, Australia
- +24 more
Aug 30, 2021
Meningococcal Vaccine Trial in Worldwide (MenABCWY, Saline, rLP2086)
Completed
- Meningococcal Vaccine
- MenABCWY
- +3 more
-
Birmingham, Alabama
- +68 more
Jan 23, 2023
Meningococcal Vaccine Trial in Germany, Greece, Spain (biological, drug, other)
Active, not recruiting
- Meningococcal Vaccine
- MenABCWY
- +8 more
-
Mannheim, Germany
- +20 more
Jun 28, 2022
MENINGOCOCCAL INFECTION Trial in Finland, Poland (Bivalent rLP2086 Vaccine, Licensed pediatric hepatits A vaccine, Normal
Completed
- MENINGOCOCCAL INFECTION
- Bivalent rLP2086 Vaccine
- +2 more
-
Espoo, Finland
- +14 more
Oct 22, 2020
Meningococcal Infection Trial in Worldwide (blood sampling, bivalent rLP2086)
Completed
- Meningococcal Infection
- blood sampling
- bivalent rLP2086
-
Chandler, Arizona
- +55 more
Mar 26, 2020
Meningitis, Meningococcal, Serogroup B Trial in Hackensack (rLP2086)
Completed
- Meningitis, Meningococcal, Serogroup B
- rLP2086
-
Hackensack, New JerseyFrontage Clinical Services (Formally ABR)
Nov 30, 2018
Vaccines, Meningococcal Vaccines Trial in United States (rLP2086 and Gardasil, rLP2086, Gardasil)
Completed
- Vaccines
- Meningococcal Vaccines
- rLP2086 and Gardasil
- +2 more
-
Daphne, Alabama
- +86 more
Nov 30, 2018
Vaccines, Meningococcal Vaccines Trial in United States (rLP2086 + MCV4 + Tdap, MCV4 + Tdap + saline, rLP2086 + saline)
Completed
- Vaccines
- Meningococcal Vaccines
- rLP2086 + MCV4 + Tdap
- +2 more
-
Birmingham, Alabama
- +116 more
Nov 30, 2018
Meningococcal Vaccine Trial in Worldwide (rLP2086, Havrix (HAV), Saline)
Completed
- Meningococcal Vaccine
- rLP2086
- +2 more
-
Birmingham, Alabama
- +98 more
May 5, 2016
Meningitis, Meningococcal Trial in South Miami (rLP2086 vaccine or control)
Completed
- Meningitis, Meningococcal
- rLP2086 vaccine or control
-
South Miami, FloridaMiami Research Associates, Inc.
Jul 15, 2015
Meningitis, Meningococcal Trial in Australia, Poland, Spain (meningococcal B rLP2086 vaccine., normal saline ())
Completed
- Meningitis, Meningococcal
- meningococcal B rLP2086 vaccine.
- normal saline (placebo)
-
Herston, Queensland, Australia
- +26 more
Mar 27, 2015
Meningococcal Vaccine, rLP2086, Repevax Trial in Finland, Germany, Poland (rLP2086, Repevax, Saline)
Completed
- Meningococcal Vaccine
- +4 more
- rLP2086
- +2 more
-
Espoo, Finland
- +35 more
Apr 27, 2015
Meningitis, Meningococcal Trial in Spain (meningococcal B rLP2086 vaccine, Routine age appropriate childhood vaccines)
Terminated
- Meningitis, Meningococcal
- meningococcal B rLP2086 vaccine
- Routine age appropriate childhood vaccines
-
Santiado de Compostela, La Coruña, Spain
- +6 more
Nov 21, 2014
Meningococcal Vaccine Trial in Worldwide (Vaccine)
Completed
- Meningococcal Vaccine
- Vaccine
-
Brandys nad Labem - Stara Boleslav, Czech Republic
- +62 more
Jun 2, 2015
Meningitis, Meningococcal Trial in Worldwide (rLP2086 vaccine, control)
Completed
- Meningitis, Meningococcal
- rLP2086 vaccine
- control
-
Huntsville, Alabama
- +85 more
Feb 25, 2015
Meningitis, Meningococcal Trial in Herston, North Adelaide, Subiaco (meningococcal B rLP2086 vaccine candidate, Blood draw)
Completed
- Meningitis, Meningococcal
- meningococcal B rLP2086 vaccine candidate
- Blood draw
-
Herston, Australia
- +2 more
Aug 22, 2011
Healthy Trial in Herson, North Adealaide, Perth (blood draw)
Completed
- Healthy
- blood draw
-
Herson, Queensland, Australia
- +2 more
Sep 15, 2009
Healthy Trial in Perth (MnB vaccine rLP8026)
Completed
- Healthy
- MnB vaccine rLP8026
-
Perth, Western Australia, Australia(unnamed)
May 6, 2008
Meningitis, Meningococcal Trial in Herson, North Adealaide, Perth (MnB rLP2086)
Completed
- Meningitis, Meningococcal
- MnB rLP2086
-
Herson, Queensland, Australia
- +2 more
Dec 3, 2007